200 related articles for article (PubMed ID: 22156611)
21. Dietary factors and microsatellite instability in sporadic colon carcinomas.
Diergaarde B; Braam H; van Muijen GN; Ligtenberg MJ; Kok FJ; Kampman E
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1130-6. PubMed ID: 14652271
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
[TBL] [Abstract][Full Text] [Related]
24. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.
Harris JE; Ryan L; Hoover HC; Stuart RK; Oken MM; Benson AB; Mansour E; Haller DG; Manola J; Hanna MG
J Clin Oncol; 2000 Jan; 18(1):148-57. PubMed ID: 10623705
[TBL] [Abstract][Full Text] [Related]
26. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
27. Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
Zaanan A; Fléjou JF; Emile JF; Des GG; Cuilliere-Dartigues P; Malka D; Lecaille C; Validire P; Louvet C; Rougier P; de Gramont A; Bonnetain F; Praz F; Taïeb J
Clin Cancer Res; 2011 Dec; 17(23):7470-8. PubMed ID: 21998335
[TBL] [Abstract][Full Text] [Related]
28. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
29. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland CR; Thibodeau SN; Hamilton SR; Sidransky D; Eshleman JR; Burt RW; Meltzer SJ; Rodriguez-Bigas MA; Fodde R; Ranzani GN; Srivastava S
Cancer Res; 1998 Nov; 58(22):5248-57. PubMed ID: 9823339
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.
Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
J Clin Pathol; 2007 Jun; 60(6):701-4. PubMed ID: 17557871
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of HLA class I expression in rectal cancer.
Speetjens FM; de Bruin EC; Morreau H; Zeestraten EC; Putter H; van Krieken JH; van Buren MM; van Velzen M; Dekker-Ensink NG; van de Velde CJ; Kuppen PJ
Cancer Immunol Immunother; 2008 May; 57(5):601-9. PubMed ID: 17874100
[TBL] [Abstract][Full Text] [Related]
32. Sporadic colorectal carcinomas with low-level microsatellite instability in Korea: do they form a distinct subgroup with distinguished clinicopathological features?
Kim YH; Min BH; Choi HK; Kim SJ; Kim KM; Kim JY; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Chun HK
J Surg Oncol; 2009 May; 99(6):351-5. PubMed ID: 19204939
[TBL] [Abstract][Full Text] [Related]
33. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
[TBL] [Abstract][Full Text] [Related]
34. Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer.
Mori T; Hirota T; Ohashi Y; Kodaira S;
Dis Colon Rectum; 2006 Jul; 49(7):982-92. PubMed ID: 16625329
[TBL] [Abstract][Full Text] [Related]
35. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M
Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
37. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
[TBL] [Abstract][Full Text] [Related]
38. Pre- and Postoperative Levels of Carcinoembryonic Antigen in Microsatellite Stable Versus Instable Colon Cancer: a Retrospective Analysis.
Salas Campos DA; Weihs D; Rosenkranz M; Langner C; Geigl JB; Tschmelitsch J; Eberl T
J Gastrointest Cancer; 2023 Jun; 54(2):600-605. PubMed ID: 35716336
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
[TBL] [Abstract][Full Text] [Related]
40. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
